World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
65661
World Ranking
4287
National Ranking
2344

Overview

Michael A. Carducci is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of Medicine, with a strong focus on oncology and related disciplines. Their research encompasses a wide range of subfields including pulmonary and respiratory medicine, oncology, radiology, nuclear medicine and imaging, molecular biology, and cancer research.

Their publication record highlights significant involvement in prostate cancer treatment and research, radiopharmaceutical chemistry and applications, and prostate cancer diagnosis and treatment. Additional areas of work include renal cell carcinoma treatment, cancer immunotherapy and biomarkers, PARP inhibition in cancer therapy, and cancer genomics and diagnostics.

Frequent publication venues for their work include:

  • Journal of Clinical Oncology
  • European Urology Oncology
  • The Prostate
  • Annals of Oncology
  • JAMA Oncology

Collaborations with other researchers have been a notable part of Carducci's career. Frequent coauthors include:

  • Channing J. Paller
  • Emmanuel S. Antonarakis
  • Mark C. Markowski
  • Samuel R. Denmeade
  • Mario A. Eisenberger

Representative recent papers authored or coauthored by Michael A. Carducci include:

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer, 2020, JAMA Oncology
  • Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial, 2020, Cancer
  • TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer, 2021, Journal of Clinical Oncology
  • The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited, 2021, European Urology
  • Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer, 2020, European Urology Oncology

Best Publications

  • Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

    Gary Hudes;Michael Carducci;Piotr Tomczak;Janice Dutcher

  • AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

    Emmanuel S. Antonarakis;Changxue Lu;Hao Wang;Brandon Luber

  • Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

    Christopher J. Sweeney;Yu Hui Chen;Michael Carducci;Glenn Liu

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

    Roland R Griffiths;Matthew W Johnson;Michael A Carducci;Annie Umbricht

  • Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

    Karim Fizazi;Michael Carducci;Matthew Smith;Ronaldo Damião

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

    Christos E. Kyriakopoulos;Yu Hui Chen;Michael A. Carducci;Glenn Liu

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Ryan Phillips;William Yue Shi;Matthew Deek;Noura Radwan

  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    Robert J. Motzer;Brian I. Rini;David F. McDermott;Osvaldo Arén Frontera

  • Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy

    Milena Braga-Basaria;Adrian S. Dobs;Denis C. Muller;Michael A. Carducci

  • Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

    Wennuan Liu;Sari Laitinen;Sofia Khan;Mauno Vihinen

  • Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

    Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo

  • Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    Emmanuel S. Antonarakis;Changxue Lu;Brandon Luber;Hao Wang

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

  • Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

    Steven D. Gore;Stephen Baylin;Elizabeth Sugar;Hetty E. Carraway

  • Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

    Emmanuel S. Antonarakis;Changxue Lu;Brandon Luber;Hao Wang

  • Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

    J.W. Simons;E.M. Jaffee;C.E. Weber;H.J. Levitsky

Frequent Co-Authors

Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
Emmanuel S. Antonarakis
Emmanuel S. Antonarakis University of Minnesota
Roberto Pili
Roberto Pili University at Buffalo, State University of New York
Maha Hussain
Maha Hussain Northwestern University
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Andrew J. Armstrong
Andrew J. Armstrong Duke University
Christopher Sweeney
Christopher Sweeney Harvard University
Phuoc T. Tran
Phuoc T. Tran Johns Hopkins University School of Medicine
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Sharyn D. Baker
Sharyn D. Baker The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but unsure if medical school is the right path, several related degrees and career options are available online. Many students start their journey in healthcare by earning a nursing degree. There are nursing school that does not require teas test options, which can streamline entry into the nursing profession, especially for those who want to avoid standardized admission tests.

For those drawn to the business and operational side of healthcare, a healthcare administration online degree can lead to management positions in hospitals, clinics, or insurance companies. Nursing professionals looking to advance can explore asn to fnp programs, bridging from an Associate Degree in Nursing (ADN) to becoming a Family Nurse Practitioner (FNP), often with flexible online options.

If nutrition and wellness are your passion, online nutrition degree programs prepare graduates for roles in dietetics, health education, or food science. These alternative online degrees can open diverse career pathways in the rapidly growing healthcare sector.

Best Scientists Citing Michael A. Carducci

Trending Scientists

Recently Published Articles